BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 28176472)

  • 1. Suspected atypical haemolytic uraemic syndrome in two post-partum patients with foetal-death in utero responding to eculizumab.
    Chua J; Paizis K; He SZ; Mount P
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():18-22. PubMed ID: 28176472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A life-threatening case of pregnancy-related atypical Haemolytic uremic syndrome and successful treatment with Eculizumab.
    Puri P; Hanxhiu A; O'Hara DV; Hsu D; Vucak-Dzumhur M
    BMC Nephrol; 2020 Nov; 21(1):488. PubMed ID: 33203373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening pregnancy-associated atypical haemolytic uraemic syndrome and its response to eculizumab.
    Gately R; San A; Kurtkoti J; Parnham A
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():32-35. PubMed ID: 28176475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse outcomes in obstetric-atypical haemolytic uraemic syndrome: a case series analysis.
    Kozlovskaya NL; Korotchaeva YV; Bobrova LA
    J Matern Fetal Neonatal Med; 2019 Sep; 32(17):2853-2859. PubMed ID: 29606012
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical haemolytic uraemic syndrome and pregnancy: outcome with ongoing eculizumab.
    Servais A; Devillard N; Frémeaux-Bacchi V; Hummel A; Salomon L; Contin-Bordes C; Gomer H; Legendre C; Delmas Y
    Nephrol Dial Transplant; 2016 Dec; 31(12):2122-2130. PubMed ID: 27587606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of thrombocytopaenia and/or microangiopathic haemolytic anaemia does not reliably exclude recurrence of atypical haemolytic uraemic syndrome after kidney transplantation.
    Krishnan AR; Siva B; Chakera A; Wong G; Wong D; Lim WH
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():28-31. PubMed ID: 28176477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
    Mallett A; Hughes P; Szer J; Tuckfield A; Van Eps C; Cambell SB; Hawley C; Burke J; Kausman J; Hewitt I; Parnham A; Ford S; Isbel N
    Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent case of pregnancy-induced atypical haemolytic uremic syndrome (P-aHUS).
    Kumar D; King M; Jim B; Acharya A
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eculizumab in secondary atypical haemolytic uraemic syndrome.
    Cavero T; Rabasco C; López A; Román E; Ávila A; Sevillano Á; Huerta A; Rojas-Rivera J; Fuentes C; Blasco M; Jarque A; García A; Mendizabal S; Gavela E; Macía M; Quintana LF; María Romera A; Borrego J; Arjona E; Espinosa M; Portolés J; Gracia-Iguacel C; González-Parra E; Aljama P; Morales E; Cao M; Rodríguez de Córdoba S; Praga M
    Nephrol Dial Transplant; 2017 Mar; 32(3):466-474. PubMed ID: 28339660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab.
    Okuda Y; Ishikura K; Terano C; Harada R; Hamada R; Hataya H; Ogata K; Honda M
    Nephrology (Carlton); 2016 Mar; 21(3):261-5. PubMed ID: 26818219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M; Tanabe K
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practical issues in using eculizumab for children with atypical haemolytic uraemic syndrome in the acute phase: A review of four patients.
    Terano C; Ishikura K; Hamada R; Yoshida Y; Kubota W; Okuda Y; Shinozuka S; Harada R; Iyoda S; Fujimura Y; Hamasaki Y; Hataya H; Honda M
    Nephrology (Carlton); 2018 Jun; 23(6):539-545. PubMed ID: 28387984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment with eculizumab in a patient with pregnancy-associated atypical hemolytic uremic syndrome.
    Duran MN; Beyazit F; Erbaş M; Özkavak O; Acar C; Bakirdogen S
    Obstet Med; 2023 Jun; 16(2):130-133. PubMed ID: 37441667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for atypical haemolytic uraemic syndrome.
    Pugh D; O'Sullivan ED; Duthie FA; Masson P; Kavanagh D
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012862. PubMed ID: 33783815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical atypical haemolytic uremic syndrome relapse following discontinuation of eculizumab.
    Choo SZ; Brown F
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():4-6. PubMed ID: 28176471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HELLP syndrome and hemolytic uremic syndrome during pregnancy: two disease entities, same causation. Case report and literature review].
    Mancini A; Ardissino G; Angelini P; Giancaspro V; La Raia E; Nisi M; Proscia A; Tarantino G; Vitale O; D'elia F
    G Ital Nefrol; 2019 Apr; 36(2):. PubMed ID: 30983177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial.
    Fakhouri F; Hourmant M; Campistol JM; Cataland SR; Espinosa M; Gaber AO; Menne J; Minetti EE; Provôt F; Rondeau E; Ruggenenti P; Weekers LE; Ogawa M; Bedrosian CL; Legendre CM
    Am J Kidney Dis; 2016 Jul; 68(1):84-93. PubMed ID: 27012908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical haemolytic uraemic syndrome in a postpartum patient.
    Hierholzer A; Majdinasab E; Young M; Kauffman RP
    BMJ Case Rep; 2023 Nov; 16(11):. PubMed ID: 37945276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report.
    Alabdulqader M; Alfakeeh K
    BMC Nephrol; 2021 Apr; 22(1):140. PubMed ID: 33879077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.